Related Experiment Video

Updated: Mar 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

A century of oncolysis evolves into oncolytic immunotherapy

O Hemminki1, A Hemminki2

  • 1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Finland; Kotka Central Hospital, Carea - Kymenlaakso Social and Health Services, Kotka, Finland.

Oncoimmunology
|April 9, 2016
PubMed

Insights

Oncolytic viruses are a promising cancer treatment, activating the immune system to fight tumors with consistent safety. Combining these immunostimulatory viruses with other therapies is being explored in ongoing clinical trials.

Area of Science:

  • Oncology
  • Immunotherapy
  • Virology

Background:

  • Oncolytic viruses represent a novel therapeutic strategy for cancer treatment.
  • This approach leverages the immune system to target and eliminate malignant cells.

Purpose of the Study:

  • To evaluate the potential of oncolytic viruses as a cancer therapy.
  • To explore the safety and efficacy of oncolytic virus treatment.
  • To investigate combination therapies involving oncolytic viruses.

Main Methods:

  • Utilizing oncolytic viruses to stimulate an anti-cancer immune response.
  • Monitoring patient safety and treatment consistency.
  • Analyzing biological correlative data for combination strategies.

Main Results:

  • The use of oncolytic viruses shows promising potency in cancer treatment.
  • Consistent safety profiles have been observed in patients.
  • Biological data suggests potential benefits from combining oncolytic viruses with other treatments.

Conclusions:

  • Oncolytic virus therapy is an increasingly appealing option for cancer patients.
  • The combination of oncolytic immunostimulatory viruses with existing treatments is a promising area for ongoing clinical trials.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

10.0K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K